This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schipani, E. Articles by Jüppner, H. Search for Related Content PubMed PubMed Citation Articles by Schipani, E. Articles by Jüppner, H.

Constitutive Activation of the Cyclic Adenosine 3',5'-Monophosphate Signaling Pathway by Parathyroid Hormone (PTH)/PTH-Related Peptide Receptors Mutated at the Two Loci for Jansen’s Metaphyseal Chondrodysplasia

Endocrine Unit (E.S., G.S.J., J.P., T.J.G., H.J.), Department of Medicine and Children’s Service (H.J.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, Department of Medicine (R.A.N.), Veterans Affairs Medical Center and University of California, San Francisco, California 94121-1545

Two different activating PTH/PTH-related peptide (PTHrP) receptor mutations, H223R and T410P, were recently identified as the most likely cause of Jansen’s metaphyseal chondrodysplasia. To assess the functional importance of either amino acid position in the human PTH/PTHrP receptor, H223 and T410 were individually replaced by all other amino acids. At position 223, only arginine and lysine led to agonist-independent cAMP accumulation; all other amino acid substitutions resulted in receptor mutants that lacked constitutive activity or were uninformative due to poor cell surface expression. In contrast, most amino acid substitutions at position 410 conferred constitutive cAMP accumulation and affected PTH/PTHrP receptor expression not at all or only mildly. Mutations corresponding to the H223R or T410P exchange in the human PTH/PTHrP receptor also led to constitutive activity when introduced into the opossum receptor homolog, but showed little or no change in basal cAMP accumulation when introduced into the rat PTH/PTHrP receptor. The PTH/PTHrP receptor residues mutated in Jansen’s disease are conserved in all mammalian members of this family of G protein-coupled receptors. However, when the equivalent of either the H223R or the T410P mutation was introduced into several other related receptors, including the PTH2 receptor and the receptors for calcitonin, secretin, GH-releasing hormone, glucagon-like peptide I, and CRH, the resulting mutants failed to induce constitutive activity. These studies suggest that two residues in the human PTH/PTHrP receptor, 223 and 410, have critical roles in signal transduction, but with different sequence constrains.

This article has been cited by other articles:

				D. Gesty-Palmer, M. Chen, E. Reiter, S. Ahn, C. D. Nelson, S. Wang, A. E. Eckhardt, C. L. Cowan, R. F. Spurney, L. M. Luttrell, et al. Distinct beta-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation J. Biol. Chem., April 21, 2006; 281(16): 10856 - 10864. [Abstract] [Full Text] [PDF]

				S. K. Shenoy, M. T. Drake, C. D. Nelson, D. A. Houtz, K. Xiao, S. Madabushi, E. Reiter, R. T. Premont, O. Lichtarge, and R. J. Lefkowitz beta-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the beta2 Adrenergic Receptor J. Biol. Chem., January 13, 2006; 281(2): 1261 - 1273. [Abstract] [Full Text] [PDF]

				M. Bastepe, A. Raas-Rothschild, J. Silver, I. Weissman, S. Wientroub, H. Juppner, and D. Gillis A Form of Jansen's Metaphyseal Chondrodysplasia with Limited Metabolic and Skeletal Abnormalities Is Caused by a Novel Activating Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3595 - 3600. [Abstract] [Full Text] [PDF]

				S. Runge, C. Gram, H. Brauner-Osborne, K. Madsen, L. B. Knudsen, and B. S. Wulff Three Distinct Epitopes on the Extracellular Face of the Glucagon Receptor Determine Specificity for the Glucagon Amino Terminus J. Biol. Chem., July 18, 2003; 278(30): 28005 - 28010. [Abstract] [Full Text] [PDF]

				M. Haywood, N. Tymchenko, J. Spaliviero, A. Koch, M. Jimenez, J. Gromoll, M. Simoni, V. Nordhoff, D. J. Handelsman, and C. M. Allan An Activated Human Follicle-Stimulating Hormone (FSH) Receptor Stimulates FSH-Like Activity in Gonadotropin-Deficient Transgenic Mice Mol. Endocrinol., November 1, 2002; 16(11): 2582 - 2591. [Abstract] [Full Text] [PDF]

				F. Beier and P. LuValle The Cyclin D1 and Cyclin A Genes Are Targets of Activated PTH/PTHrP Receptors in Jansen's Metaphyseal Chondrodysplasia Mol. Endocrinol., September 1, 2002; 16(9): 2163 - 2173. [Abstract] [Full Text] [PDF]

				D. W. Soegiarto, S. Kiachopoulos, E. Schipani, H. Juppner, R. G. Erben, and B. Lanske Partial Rescue of PTH/PTHrP Receptor Knockout Mice by Targeted Expression of the Jansen Transgene Endocrinology, December 1, 2001; 142(12): 5303 - 5310. [Abstract] [Full Text] [PDF]

				F. Beier, Z. Ali, D. Mok, A. C. Taylor, T. Leask, C. Albanese, R. G. Pestell, and P. LuValle TGFbeta and PTHrP Control Chondrocyte Proliferation by Activating Cyclin D1 Expression Mol. Biol. Cell, December 1, 2001; 12(12): 3852 - 3863. [Abstract] [Full Text] [PDF]

				E. J. Lee, T. J. Kotlar, I. Ciric, M. K. Lee, S. K. Lim, H. C. Lee, K. B. Huh, K. E. Mayo, and J. L. Jameson Absence of Constitutively Activating Mutations in the GHRH Receptor in GH-Producing Pituitary Tumors J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3989 - 3995. [Abstract] [Full Text] [PDF]

				J.-P. Vilardaga, I. Lin, and R. A. Nissenson Analysis of Parathyroid Hormone (PTH)/Secretin Receptor Chimeras Differentiates the Role of Functional Domains in the PTH/ PTH-Related Peptide (PTHrP) Receptor on Hormone Binding and Receptor Activation Mol. Endocrinol., July 1, 2001; 15(7): 1186 - 1199. [Abstract] [Full Text] [PDF]

				P. H. Carter, B. D. Petroni, R. C. Gensure, E. Schipani, J. T. Potts Jr., and T. J. Gardella Selective and Nonselective Inverse Agonists for Constitutively Active Type-1 Parathyroid Hormone Receptors: Evidence for Altered Receptor Conformations Endocrinology, April 1, 2001; 142(4): 1534 - 1545. [Abstract] [Full Text]

				J. Guo, B. Lanske, B.-Y. Liu, P. Divieti, H. M. Kronenberg, and F. R. Bringhurst Signal-Selectivity of Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor-Mediated Regulation of Differentiation in Conditionally Immortalized Growth-Plate Chondrocytes Endocrinology, March 1, 2001; 142(3): 1260 - 1268. [Abstract] [Full Text] [PDF]

				S. L. Ferrari and A. Bisello Cellular Distribution of Constitutively Active Mutant Parathyroid Hormone (PTH)/PTH-Related Protein Receptors and Regulation of Cyclic Adenosine 3',5'-Monophosphate Signaling by {beta}-Arrestin2 Mol. Endocrinol., January 1, 2001; 15(1): 149 - 163. [Abstract] [Full Text]

				S. M. Nielsen, L. Z. Nielsen, S. A. Hjorth, M. H. Perrin, and W. W. Vale Constitutive activation of tethered-peptide/ corticotropin-releasing factor receptor chimeras PNAS, August 29, 2000; 97(18): 10277 - 10281. [Abstract] [Full Text] [PDF]

				J. Van Wyk Insulin-Like Growth Factors and Skeletal Growth: Possibilities for Therapeutic Interventions J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4349 - 4354. [Full Text]

				D. G. McEwen, R. P. Green, M. C. Naski, D. A. Towler, and D. M. Ornitz Fibroblast Growth Factor Receptor 3 Gene Transcription Is Suppressed by Cyclic Adenosine 3',5'-Monophosphate. IDENTIFICATION OF A CHONDROCYTIC REGULATORY ELEMENT J. Biol. Chem., October 22, 1999; 274(43): 30934 - 30942. [Abstract] [Full Text] [PDF]

				A. J. Morris and C. C. Malbon Physiological Regulation of G Protein-Linked Signaling Physiol Rev, October 1, 1999; 79(4): 1373 - 1430. [Abstract] [Full Text] [PDF]

				E. Schipani, C. Langman, J. Hunzelman, M. Le Merrer, K. Y. Loke, M. J. Dillon, C. Silve, and H. Jüppner A Novel Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation in Jansen's Metaphyseal Chondrodysplasia J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3052 - 3057. [Abstract] [Full Text]

				R. A. Nissenson Editorial: Parathyroid Hormone (PTH)/PTHrP Receptor Mutations in Human Chondrodysplasia Endocrinology, December 1, 1998; 139(12): 4753 - 4755. [Full Text] [PDF]

				P. R. Turner, S. Mefford, T. Bambino, and R. A. Nissenson Transmembrane Residues Together with the Amino Terminus Limit the Response of the Parathyroid Hormone (PTH) 2 Receptor to PTH-related Peptide J. Biol. Chem., February 13, 1998; 273(7): 3830 - 3837. [Abstract] [Full Text] [PDF]

				S. A. Hjorth, C. Ørskov, and T. W. Schwartz Constitutive Activity of Glucagon Receptor Mutants Mol. Endocrinol., January 1, 1998; 12(1): 78 - 86. [Abstract] [Full Text]